Literature DB >> 27153315

IGF2BP2 promotes colorectal cancer cell proliferation and survival through interfering with RAF-1 degradation by miR-195.

Song Ye1, Wei Song2, Xiaogang Xu3, Xinyi Zhao2, Liu Yang3,4.   

Abstract

Insulin-like growth factor 2 (IGF2) mRNA-binding protein 2 (IGF2BP2) is a post-transcriptional regulatory factor implicated in mRNA localization, stability, and translational control. However, the role of IGF2BP2 regulation in colorectal cancer (CRC) and its underlying mechanism remain elusive. In this study, we found that IGF2BP2 expression is markedly increased in CRC tissues. Notably, IGF2BP2 overexpression strikingly enhanced the proliferation and survival of CRC cells in vitro, whereas its shRNA-mediated silencing resulted in the opposite. Molecular function analyses revealed that IGF2BP2 regulates RAF1 expression through blocking its degradation by miR-195. These results identify IGF2BP2 as a post-transcriptional regulatory mRNA-binding factor that contributes to CRC carcinogenesis.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  IGF2BP2; RAF1; RNA-binding proteins; colorectal cancer; miR-195

Mesh:

Substances:

Year:  2016        PMID: 27153315     DOI: 10.1002/1873-3468.12205

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  34 in total

Review 1.  The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers.

Authors:  Jinyan Wang; Lijuan Chen; Ping Qiang
Journal:  Cancer Cell Int       Date:  2021-02-10       Impact factor: 5.722

2.  Expression profile, clinical significance and biological functions of IGF2BP2 in esophageal squamous cell carcinoma.

Authors:  Fenying Lu; Weichang Chen; Tingwang Jiang; Cuie Cheng; Bin Wang; Zhiping Lu; Guojin Huang; Jiaming Qiu; Wei Wei; Ming Yang; Xia Huang
Journal:  Exp Ther Med       Date:  2022-02-01       Impact factor: 2.447

3.  Bioinformatical identification of key genes regulated by IGF2BP2-mediated RNA N6-methyladenosine and prediction of prognosis in hepatocellular carcinoma.

Authors:  Qiang Wei
Journal:  J Gastrointest Oncol       Date:  2021-08

4.  LCAT1 is an oncogenic LncRNA by stabilizing the IGF2BP2-CDC6 axis.

Authors:  Juze Yang; Xinyi Qian; Qiongzi Qiu; Lingling Xu; Meidie Pan; Jia Li; Jiayi Ren; Bingjian Lu; Ting Qiu; Enguo Chen; Kejing Ying; Honghe Zhang; Yan Lu; Pengyuan Liu
Journal:  Cell Death Dis       Date:  2022-10-18       Impact factor: 9.685

Review 5.  MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Colorectal Cancer.

Authors:  Fangfang Yang; Guoyun Xuan; Yixin Chen; Lichao Cao; Min Zhao; Chen Wang; Erfei Chen
Journal:  Front Cell Dev Biol       Date:  2022-04-08

6.  LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.

Authors:  Bing Liu; Yifei Chen; Jiong Yang
Journal:  Oncotarget       Date:  2017-04-11

7.  Decrease of miR-195 Promotes Chondrocytes Proliferation and Maintenance of Chondrogenic Phenotype via Targeting FGF-18 Pathway.

Authors:  Yong Wang; Tao Yang; Yadong Liu; Wei Zhao; Zhen Zhang; Ming Lu; Weiguo Zhang
Journal:  Int J Mol Sci       Date:  2017-05-04       Impact factor: 5.923

Review 8.  The biological function of IGF2BPs and their role in tumorigenesis.

Authors:  Qiu-Ying Du; Zhi-Man Zhu; Dong-Sheng Pei
Journal:  Invest New Drugs       Date:  2021-07-12       Impact factor: 3.850

9.  FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis.

Authors:  Dan-Yun Ruan; Ting Li; Ying-Nan Wang; Qi Meng; Yang Li; Kai Yu; Min Wang; Jin-Fei Lin; Li-Zhi Luo; De-Shen Wang; Jun-Zhong Lin; Long Bai; Ze-Xian Liu; Qi Zhao; Xiang-Yuan Wu; Huai-Qiang Ju; Rui-Hua Xu
Journal:  Oncogene       Date:  2021-07-03       Impact factor: 9.867

10.  m6A modification promotes miR-133a repression during cardiac development and hypertrophy via IGF2BP2.

Authors:  Benheng Qian; Ping Wang; Donghong Zhang; Lianpin Wu
Journal:  Cell Death Discov       Date:  2021-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.